PMID- 16542320
OWN - NLM
STAT- MEDLINE
DCOM- 20061003
LR  - 20191210
IS  - 0065-1591 (Print)
IS  - 0065-1591 (Linking)
IP  - 430
DP  - 2006
TI  - The Canadian National Outcomes Measurement Study in Schizophrenia: overview of 
      the patient sample and methodology.
PG  - 4-11
AB  - OBJECTIVE: The Canadian National Outcomes Measurement Study in Schizophrenia 
      (CNOMSS) is a prospective survey of routine clinical practice. METHOD: Patients 
      with schizophrenia or a related disorder were consecutively enrolled from all 
      regions of Canada. Both academic and community psychiatric clinics were included 
      and patients were followed up for 2 years. Clinical and functional status, 
      quality of life, medication and economic costs were assessed at enrollment and 
      monitored throughout the follow-up period. RESULTS: Patients attending an 
      academic clinic tended to be younger and more severely ill than those from 
      community clinics. Both types of sites prescribed atypical neuroleptics to more 
      than three-quarters of the patients. The majority of those enrolled were 
      unemployed and living in poverty. Poor clinical status was associated with 
      poverty. CONCLUSION: The CNOMSS provides demographic, clinical and 
      treatment-related information about a large Canada-wide sample of psychiatric 
      patients. The following three articles in this issue of Acta Psychiatrica 
      Scandinavica explore issues related to medication, quality of life and resource 
      utilization.
FAU - Smith, G
AU  - Smith G
AD  - Department of Psychiatry, University of British Columbia, Vancouver, BC, Canada. 
      geoffsm@interchange.ubc.ca
FAU - Malla, A
AU  - Malla A
FAU - Williams, R
AU  - Williams R
FAU - Kopala, L
AU  - Kopala L
FAU - Love, L
AU  - Love L
FAU - Balshaw, R
AU  - Balshaw R
LA  - eng
PT  - Journal Article
PT  - Multicenter Study
PT  - Research Support, Non-U.S. Gov't
PL  - Denmark
TA  - Acta Psychiatr Scand Suppl
JT  - Acta psychiatrica Scandinavica. Supplementum
JID - 0370365
RN  - 0 (Psychotropic Drugs)
SB  - IM
MH  - Academic Medical Centers/*statistics & numerical data
MH  - Adult
MH  - Age Factors
MH  - Canada
MH  - Community Mental Health Centers/*statistics & numerical data
MH  - Data Collection/*methods
MH  - Female
MH  - Follow-Up Studies
MH  - Health Care Surveys
MH  - Health Status
MH  - Humans
MH  - Male
MH  - Outcome Assessment, Health Care/*methods
MH  - Poverty
MH  - Prospective Studies
MH  - Psychiatric Status Rating Scales
MH  - Psychotropic Drugs/therapeutic use
MH  - Quality of Life/psychology
MH  - Sample Size
MH  - *Schizophrenia/drug therapy/economics
MH  - Schizophrenic Psychology
MH  - Severity of Illness Index
EDAT- 2006/03/18 09:00
MHDA- 2006/10/04 09:00
CRDT- 2006/03/18 09:00
PHST- 2006/03/18 09:00 [pubmed]
PHST- 2006/10/04 09:00 [medline]
PHST- 2006/03/18 09:00 [entrez]
AID - ACP756 [pii]
AID - 10.1111/j.1600-0447.2006.00756.x [doi]
PST - ppublish
SO  - Acta Psychiatr Scand Suppl. 2006;(430):4-11. doi: 
      10.1111/j.1600-0447.2006.00756.x.